Jasper Therapeutics Ownership | Who Owns Jasper Therapeutics?

Jasper Therapeutics Ownership Summary

Jasper Therapeutics is owned by 9.29% institutional investors, 1.05% insiders, and 89.66% retail investors. Velan capital investment management lp is the largest institutional shareholder, holding 17.76% of JSPR shares. Polar Capital Healthcare Opports Inc is the top mutual fund, with 3.85% of its assets in Jasper Therapeutics shares.

JSPR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Jasper Therapeutics	9.29%	1.05%	89.66%
Sector	Healthcare Stocks	231.98%	10.74%	-142.72%
Industry	Biotech Stocks	381.47%	10.55%	-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Velan capital investment management lp	2.67M	17.76%	$6.21M
Morgan stanley	1.97M	11.88%	$3.60M
Goldman sachs group	1.75M	10.53%	$3.20M
Acorn capital advisors	1.38M	9.20%	$3.29M
Kingdon capital management	1.32M	8.82%	$3.15M
Vanguard group	1.33M	8.00%	$2.43M
Rock springs capital management lp	1.10M	7.33%	$2.62M
Carlyle group	1.07M	7.10%	$2.53M
Woodline partners lp	1.04M	6.92%	$2.47M
T. rowe price investment management	1.03M	6.85%	$2.45M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Velan capital investment management lp	2.67M	5.83%	$6.21M
Lion point capital, lp	398.56K	5.39%	$948.57K
Qiming u.s. ventures management	928.96K	3.97%	$2.21M
Acorn capital advisors	1.38M	1.67%	$3.29M
Kingdon capital management	1.32M	0.39%	$3.15M
Sphera funds management	629.47K	0.32%	$1.50M
Knott david m jr	181.39K	0.15%	$331.94K
Rock springs capital management lp	1.10M	0.15%	$2.62M
Carlyle group	1.07M	0.06%	$2.53M
Boothbay fund management	442.64K	0.02%	$1.05M

Top Buyers

Holder	Shares	% Assets	Change
Goldman sachs group	1.75M	0.00%	1.72M
Acorn capital advisors	1.38M	1.67%	1.38M
Velan capital investment management lp	2.67M	5.83%	1.23M
Morgan stanley	1.97M	0.00%	1.18M
Woodline partners lp	1.04M	0.01%	1.04M

Top Sellers

Holder	Shares	% Assets	Change
Soleus capital management	200.00K	0.01%	-1.29M
Propel bio management	-	-	-1.03M
Braidwell lp	-	-	-714.66K
Simplify asset management	-	-	-609.05K
Integral health asset management	-	-	-590.00K

New Positions

Holder	Shares	% Assets	Change	Value
Acorn capital advisors	1.38M	1.67%	1.38M	$3.29M
Woodline partners lp	1.04M	0.01%	1.04M	$2.47M
Boothbay fund management	442.64K	0.02%	442.64K	$1.05M
Armistice capital	348.00K	0.01%	348.00K	$828.24K
Readystate asset management lp	98.44K	0.01%	98.44K	$234.28K

Sold Out

Holder	Change
Rossby financial, lcc	-2.00
Sterling capital management	-12.00
Wolff wiese magana	-15.00
Coldstream capital management	-38.00
Eversource wealth advisors	-65.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	7	-89.06%	1,540,911	-92.35%	9	0.05%	3	-90.91%	2	-88.89%
Sep 30, 2025	12	-80.33%	3,749,017	-66.07%	24	0.46%	6	-81.82%	3	-78.57%
Jun 30, 2025	65	-2.99%	12,501,153	8.39%	83	1.33%	35	16.67%	15	-34.78%
Mar 31, 2025	70	-24.73%	13,034,411	-16.69%	89	0.78%	32	-38.46%	23	35.29%
Dec 31, 2024	92	10.84%	15,645,934	6.60%	107	1.12%	51	15.91%	17	-10.53%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Polar Capital Healthcare Opports Inc	581.54K	3.85%	-
Vanguard Total Stock Mkt Idx Inv	833.39K	2.98%	-
Franklin Biotechnology Discv A(acc)USD	339.25K	2.26%	-
T. Rowe Price Small-Cap Value	548.29K	1.96%	-23.54K
iShares Russell 2000 ETF	285.63K	1.90%	-
HBM Healthcare Investments AG Ord	250.00K	1.67%	-
T. Rowe Price U.S. SC Value Eq Tr-Z	245.81K	1.64%	217.41K
Fidelity Select Health Care	208.04K	1.39%	208.04K
T. Rowe Price U.S. SC Value Eq Tr-D	385.52K	1.38%	520.00
Franklin Biotechnology Discovery A	195.44K	1.30%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 22, 2025	WIGGANS THOMAS G	-	Buy	$119.72K
Sep 22, 2025	WIGGANS THOMAS G	-	Buy	$99.63K
Sep 22, 2025	Lucas Svetlana	-	Buy	$48.60K
Sep 22, 2025	Lucas Svetlana	-	Buy	$58.40K
Sep 22, 2025	MARTELL RON	President and CEO	Buy	$99.63K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	8	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	1
2024 Q3	-	1

JSPR Ownership FAQ

Who Owns Jasper Therapeutics?

Jasper Therapeutics shareholders are primarily institutional investors at 9.29%, followed by 1.05% insiders and 89.66% retail investors. The average institutional ownership in Jasper Therapeutics's industry, Biotech Stocks , is 381.47%, which Jasper Therapeutics falls below.

Who owns the most shares of Jasper Therapeutics?

Jasper Therapeutics’s largest shareholders are Velan capital investment management lp (2.67M shares, 17.76%), Morgan stanley (1.97M shares, 11.88%), and Goldman sachs group (1.75M shares, 10.53%). Together, they hold 40.18% of Jasper Therapeutics’s total shares outstanding.

Does Blackrock own Jasper Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Jasper Therapeutics.

Who is Jasper Therapeutics’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Jasper Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.83% of its assets in 2.67M Jasper Therapeutics shares, valued at 6.21M$.

Who is the top mutual fund holder of Jasper Therapeutics shares?

Polar Capital Healthcare Opports Inc is the top mutual fund holder of Jasper Therapeutics shares, with 3.85% of its total shares outstanding invested in 581.54K Jasper Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools